Sneddon Syndrome:CT, Arteriography, and MR Imaging
J Comput Assist Tomogr 13:119-122, Blom,R.J., 1989
Severely Threatening Events and Marked Life Difficulties Preceding Onset or Exacerbation of MS
JNNP 52:8-13, Grant,I.,et al, 1989
Hemorrhagic Shock and Encephalopathy:Clinical, Pathologic, and Biochemical Features
J Pediatr 114:194-203, Levin,M.,et al, 1989
Cerebral Magnetic Resonance Imaging Findings in MS, Relation to Affect, Drive and Cognition
Arch Neurol 45:1114-1116, Reischies,F.M.,et al, 1988
Prediction of Delayed Cerebral Ischemia, Rebleeding, and Outcome After Aneurysmal Subarachnoid Hemorrhage
Stroke 19:1250-1256, Hijdra,A.,et al, 1988
Risk of Developing Multiple Sclerosis after Uncomplicated Optic Neuritis:A Long-Term Prospective Study
Neurol 38:185-190, Rizzo,J.F.&Lessell,S., 1988
Malignant Monophasic Multiple Sclerosis or"Marburg's Disease"
Neurol 38:1153-1155, Mendez,M.F.&Pogacar,S., 1988
Results of the Seven-Year Prospective Study of Stroke Patients
Stroke 19:942-949, Scmidt,E.V.,et al, 1988
A Prospective Study of Acute Idiopathic Neuropathy, I, Clinical Features & Their Prognostic Value
JNNP 51:605-612, Winer,J.B.,et al, 1988
Immunologic Aspects of Neurological & Neuromuscular Diseases
JAMA 258:2970-2973, Zweiman,B.&Arnason,B.G.W., 1987
Clinical Assessment of 31 Patients with Wilson's Disease, Correlations with Struct. Changes on MRI
Arch Neurol 44:365-370, Starosta-Rubinstein,S.,et al, 1987
Survival Pattern & Cause of Death in Patients with MS:Results From an Epidemiological Survey in North East Scotland
JNNP 50:523-531, Phadke,J.G., 1987
Is Multiple Sclerosis Caused by an Oral Spirochaete
Lancet 2:75-77, Gay,D.&Dick,G., 1986
Clinicopathological Conference
Case 2-1984, Fabry's Disease, NEJM 310:106-114984., , 1984
Multiple Sclerosis, (Second of Two Parts)
NEJM 307:1246-1251, McFarlin,D.E.,et al, 1982
Isolation Of Virus From The Spinal Fluid Of Three Patients with Multiple Sclerosis & One With ALS
Lancet 1:830-833, Melnick,J.L.,et al, 1982
Dorsal Midbrain Syndrome in Multiple Sclerosis
Neurol 31:196-198, Slyman,J.F.,et al, 1981
Trauma As An Etiologic & Aggravating Factor in Multiple Sclerosis
Neurol 31:1229-1234, Bamford,C.R.,et al, 1981
Psychological Profiles in Patients With Multiple Sclerosis, A Preliminary Investigation
Arch Neurol 37:437-440, Peyser,J.M.,et al, 1980
Multiple Sclerosis & Hysteria, Lessons Learned From Their Association
JAMA 243:2418-2421, Caplan,L.R.,et al, 1980
Depression as a Major Symptom of Multiple Sclerosis
JNNP 43:861-865, Whitlock,F.A.,et al, 1980
Multiple Sclerosis Presenting with Acute Remitting Psychiatric Symptoms
JNNP 42:859-863, Matthews,W.B., 1979
Multiple Sclerosis & House Dogs:A Case-control Study
Neurol 29:1027-1029, Bunnell,D.H.,et al, 1979
The Year of the Dog
Neurol 29:1023-1026, Alter,M.,et al, 1979
The Association of Multiple Sclerosis with Domestic Animals & Household Pets
Ann Neurol 5:207-208, Sylwester,D.L.,et al, 1979
Multiple Sclerosis & Canine Pets
Ann Neurol 3:97, Kurland,L.,et al, 1978
Further Evidence of a Possible Association Between House Dogs & Multiple Sclerosis
Ann Neurol 3:141, Cook,S.C.,et al, 1978
Neurological Manifestations of Fabry Disease in Female Carriers
Ann Neurol 4:537-540, Bird,T.D.,et al, 1978
Recovery of Paramyxovirus from the Jejunum of Patients with Multiple Sclerosis
Lancet p. 117, May 28977., Prasad,I.,et al, 1977
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Specific Laboratory Test for Diagnosis of MS
BMJ 1:412, Field,E.J.,et al, 1974
Organic Disease Presenting as a Psychiatric Syndrome
Postgrad Med 54:78, , 1973
Thromboangiitis Obliterans Cerebri
Edited by, Vinken, E. , Handbook Clinical Neurol 12:3842., Bernsmeier,A.&Held,K., 1972
Fusion of Cultured Multiple-Sclerosis Brain Cells with Indicator Cells:Isolate of Parainfluenza-Type Virus
Lancet 7766, 1972, July., Meulen,V.,et al, 1972
A 60-Year-Old Man with Rapidly Progressive Left Hemibody Weakness and Vision Loss
Neurol 105: e213869, Rock,M.,et al, 2025
Clinicopathological Conference, Powasan Virus Encephalitis
NEJM 393:176-184, Case 19-2025, 2025
Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025
Rapidly Progressive Frontotemporal Dementia with Amytrophic Lateral Sclerosis in an Elderly Female
Cureus doi:10.7759/CUREUS.32182, Sweedan,Y.G.,et al, 2025
Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis Clinic
Neurol 105:e213912, Remner,B.,et al, 2025
Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
Ann Neurol 96:846-854, Marrodan,M.,et al, 2024
Clinicopathologic Conference, Psychotic Disorder Due to a General Medical Condition (postictal psychosis)
NEJM 391:2036-2046, Case 37-2024, 2024
Clinicopathologic Conference, Infective Endocarditis Due to Haemophilus Parainfluenza
NEJM 391:2148-2157, Case 38-2024, 2024
Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Ann Neurol 96:1086-1091, Fadda,G.,et al, 2024
Recurrent Ischemic Stroke in Patients with Atrial Fibrillation Whle Receiving Oral Anticoagulants
JAMA Neurol 81:805-813, Hindsholm,M.F.,et al, 2024
MR Imaging Findings in Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis:A Systematic Review and Meta-Analysis
AJNR 45:977-986, Almeida,F.C.,et al, 2024
Uncommon Causes of Nontraumatic Intracerebral Hemorrhage
Stroke 55:1416-1427, Tartarin,H.,et al, 2024
Decompressive Carniectomy Plus Best Medical Treatment Versus Best Medical Treatment Alone for Spontaneous Severe Deep Supratentorial Intracerebral Haemorrhage:A Randomised Controlled Clinical Trial
Lancet 403:2395-2404, Beck,J.,et al, 2024
Clinicopathologic Conference, Paraneoplastic Encephalomyelitis Due to Small-Cell Lung Carcinoma and Concurrent Cerebral Amyloid Angiopathy
NEJM< 391357-369, Case 23-2024, 2024
The Optic Nerve Should Graduate to Be the Fifth Lesion Site for the Diagnosis of Multiple Sclerosis
Neurol 102:e207919, Galetta,S. & Brownlee, W., 2024
Adverse Events Associated with Disease-Modifying Drugs for Multiple Sclerosis
Neurol 102:e208006, Ng, HS.,et al, 2024